Mandy L. Ballinger

The University of Sydney — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index3.4kcitations199works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(63), BRCA gene mutations in cancer(40), Cancer-related Molecular Pathways(30), Sarcoma Diagnosis and Treatment(28), Genomics and Rare Diseases(25)

Publications198 total

Development of a question prompt list to support Consent for Genomic Testing (CoGenT) and research
2026Open Access
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation
JCO Precision Oncology·2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma
Clinical Cancer Research·2026
Nivolumab and Ipilimumab in Advanced Mismatch Repair–Deficient/Microsatellite Instability–High Noncolorectal Cancers
JAMA Oncology·2025· 1 cited
PATH-52. Understanding the prevalence of <i>MTAP</i> and <i>CDKN2A/B</i> deletion in gliomas by next generation sequencing
Neuro-Oncology·2025Open Access
TIP-16. Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study
Neuro-Oncology·2025Open Access
Implementation of precision medicine in treating non-communicable diseases: a systematic review
Journal of Translational Medicine·2025· 1 citedOpen Access
P2.06.61 ASPiRATION. Australian Nationwide Cohort Study to Assess Impact of Comprehensive Genomic Profiling in Metastatic Lung Cancer
Journal of Thoracic Oncology·2025
Integration of precision medicine into routine cancer care—protocol for the Precision Care Initiative: a research programme of effectiveness-implementation hybrid trials
BMJ Open·2025Open Access
<i>SMARCAL1</i> is a new osteosarcoma predisposition gene
JNCI Journal of the National Cancer Institute·2025· 1 citedOpen Access
Interventions to support patient decision making about taking part in health research: A systematic review
Patient Education and Counseling·2025· 2 citedOpen Access
973P Phase II trial of Vismodegib in advanced cancers with Hedgehog pathway alterations
Annals of Oncology·2025
2715P Phase II trial of tildrakizumab in treatment-refractory bone and soft tissue sarcomas
Annals of Oncology·2025
A Robust BERT-Based Deep Learning Model for Automated Cancer Type Extraction from Unstructured Pathology Reports
arXiv (Cornell University)·2025Open Access
Automating Precision Oncology Literature Curation: A Decision Tree Approach Using Large Language Models
Studies in health technology and informatics·2025Open Access
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers
JAMA Oncology·2025· 9 citedOpen Access
Machine learning–based classification of cancer types using genomic profiling data from the Australian Molecular Screening and Therapeutics (MoST) program.
Journal of Clinical Oncology·2025
Genomic and outcome analysis of recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC) receiving systemic therapy: Results from the Australian MoST and CaSP screening programs.
Journal of Clinical Oncology·2025
Population-based assessment of leiomyosarcoma (LMS) and cancers in the Li-Fraumeni syndrome (LFS) spectrum: Implications for genetic testing criteria.
Journal of Clinical Oncology·2025
Clinical and economic value of comprehensive genomic profiling in patients with advanced solid cancers using Australian real-world data: Preliminary analyses.
Journal of Clinical Oncology·2025
page 1 of 10Next →

Frequent Co-authors

David M. Thomas(27), Peter J. Little(19), Narin Osman(14), Paul A. James(9), Robel Getachew(8), Sharon A. Savage(7), Bettina Meiser(7), Phyllis Butow(7), Gillian Mitchell(6), Mary‐Anne Young(6), Micah L. Burch(6), Megan Best(6), Julie Nigro(5), Kathy Tucker(5), Ilona Juraskova(5), Judy Kirk(4), L. Phuong(4), Louise C. Strong(4), Timothy E. Schlub(4), Nicci Bartley(4)